ClinicalTrials.govpublic full text
Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas
pancreatic ductal adenocarcinoma, pancreatic cancer, sirna, rna interference (rnai), cancer, solid tumor, operable pancreatic ductal adenocarcinoma, non operable pancreatic ductal adenocarcinoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 910830
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.